Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2013

01.06.2013 | Brief Report

Adherence to screening mammography among American Indian women of the northern plains

verfasst von: Emily L. Roen, Marilyn A. Roubidoux, Annette I. Joe, Tina R. Russell, Amr S. Soliman

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is a burden for American Indian (AI) women who have younger age at diagnosis and higher stage of disease. Rural areas also have had less access to screening mammography. An Indian Health Service Mobile Women’s Health Unit (MWHU) was implemented to improve mammogram screening of AI women in the Northern Plains. Our purpose was to determine the past adherence to screening mammography at a woman’s first presentation to the MWHU for mammogram screening. Date of the most recent prior non-MWHU mammogram was obtained from mammography records. Adherence to screening guidelines was defined as the prior mammogram occurring 1–2 years before the first MWHU visit among women >41 years, and was the main outcome, whereas, age and clinic site were predictors. Adherence was compared with national data of the Breast Cancer Surveillance Consortium (BCSC). Among 1,771 women >41 years, adherence to screening mammography guidelines was 48.01 % among >65 years, 42.05 % among 50–64 years, 33.43 % among 41–49 years, and varied with clinic site (25.23–65.93 %). Age (p < 0.0001) and clinic site (p < 0.0001) were associated with adherence. Overall, adherence to screening mammography guidelines was found in 39.86 % (706/1771) of MWHU women versus 74.34 % (747,095/1,004,943) of BCSC women. The majority (60.14 %) of women at first presentation to the MWHU had not had mammograms in the previous 2 years, lower screening adherence than nationally (25.66 %). Adherence was lowest among women ages 41–49, and varied with clinic site. Findings suggest disparities in mammography screening among these women.
Literatur
2.
Zurück zum Zitat Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomarkers Prev 18(1):121–131PubMedCrossRef Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomarkers Prev 18(1):121–131PubMedCrossRef
3.
Zurück zum Zitat Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56PubMedCrossRef Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56PubMedCrossRef
4.
Zurück zum Zitat Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, Jackson-Thompson J, Arambula Solomon TG (2008) Breast cancer incidence among American Indian and Alaska Native women: US, 1999–2004. Cancer 113(5 Suppl):1191–1202PubMedCrossRef Wingo PA, King J, Swan J, Coughlin SS, Kaur JS, Erb-Alvarez JA, Jackson-Thompson J, Arambula Solomon TG (2008) Breast cancer incidence among American Indian and Alaska Native women: US, 1999–2004. Cancer 113(5 Suppl):1191–1202PubMedCrossRef
5.
Zurück zum Zitat Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK (2002) Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology, and end results) Program population-based study. Arch Intern Med 162(17):1985–1993PubMedCrossRef Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK (2002) Cancer survival among US whites and minorities: a SEER (surveillance, epidemiology, and end results) Program population-based study. Arch Intern Med 162(17):1985–1993PubMedCrossRef
6.
Zurück zum Zitat Amey CH, Miller MK, Albrecht SL (1997) The role of race and residence in determining stage at diagnosis of breast cancer. J Rural Health 13(2):99–108PubMedCrossRef Amey CH, Miller MK, Albrecht SL (1997) The role of race and residence in determining stage at diagnosis of breast cancer. J Rural Health 13(2):99–108PubMedCrossRef
7.
Zurück zum Zitat Barry J, Breen N (2005) The importance of place of residence in predicting late-stage diagnosis of breast or cervical cancer. Health Place 11(1):15–29PubMedCrossRef Barry J, Breen N (2005) The importance of place of residence in predicting late-stage diagnosis of breast or cervical cancer. Health Place 11(1):15–29PubMedCrossRef
8.
Zurück zum Zitat Lee-Feldstein A, Feldstein PJ, Buchmueller T, Katterhagen G (2000) The relationship of HMOs, health insurance, and delivery systems to breast cancer outcomes. Med Care 38(7):705–718PubMedCrossRef Lee-Feldstein A, Feldstein PJ, Buchmueller T, Katterhagen G (2000) The relationship of HMOs, health insurance, and delivery systems to breast cancer outcomes. Med Care 38(7):705–718PubMedCrossRef
9.
Zurück zum Zitat Menck HR, Mills PK (2001) The influence of urbanization, age, ethnicity, and income on the early diagnosis of breast carcinoma: opportunity for screening improvement. Cancer 92(5):1299–1304PubMedCrossRef Menck HR, Mills PK (2001) The influence of urbanization, age, ethnicity, and income on the early diagnosis of breast carcinoma: opportunity for screening improvement. Cancer 92(5):1299–1304PubMedCrossRef
10.
Zurück zum Zitat Taplin SH, Ichikawa L, Yood MU, Manos MM, Geiger AM, Weinmann S, Gilbert J, Mouchawar J, Leyden WA, Altaras R et al (2004) Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 96(20):1518–1527PubMedCrossRef Taplin SH, Ichikawa L, Yood MU, Manos MM, Geiger AM, Weinmann S, Gilbert J, Mouchawar J, Leyden WA, Altaras R et al (2004) Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst 96(20):1518–1527PubMedCrossRef
11.
Zurück zum Zitat Kauhava L, Immonen-Raiha P, Parvinen I, Holli K, Kronqvist P, Pylkkanen L, Helenius H, Kaljonen A, Rasanen O, Klemi PJ (2006) Population-based mammography screening results in substantial savings in treatment costs for fatal breast cancer. Breast Cancer Res Treat 98(2):143–150PubMedCrossRef Kauhava L, Immonen-Raiha P, Parvinen I, Holli K, Kronqvist P, Pylkkanen L, Helenius H, Kaljonen A, Rasanen O, Klemi PJ (2006) Population-based mammography screening results in substantial savings in treatment costs for fatal breast cancer. Breast Cancer Res Treat 98(2):143–150PubMedCrossRef
12.
Zurück zum Zitat Kopans DB (2007) Screening for Breast Cancer. In: Williams L, Wilkins (eds) Breast imaging, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 121–190 Kopans DB (2007) Screening for Breast Cancer. In: Williams L, Wilkins (eds) Breast imaging, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 121–190
13.
Zurück zum Zitat Nickson C, Mason KE, English DR, Kavanagh AM (2012) Mammographic Screening and breast cancer mortality: a case–control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 21(9):1479–1488PubMedCrossRef Nickson C, Mason KE, English DR, Kavanagh AM (2012) Mammographic Screening and breast cancer mortality: a case–control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 21(9):1479–1488PubMedCrossRef
14.
Zurück zum Zitat Peek ME, Han JH (2004) Disparities in screening mammography. Current status, interventions and implications. J Gen Intern Med 19(2):184–194PubMedCrossRef Peek ME, Han JH (2004) Disparities in screening mammography. Current status, interventions and implications. J Gen Intern Med 19(2):184–194PubMedCrossRef
15.
Zurück zum Zitat Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, Dignan M, Barlow WE, Beasley CM, Kerlikowske K (2006) Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144(8):541–553PubMedCrossRef Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, Dignan M, Barlow WE, Beasley CM, Kerlikowske K (2006) Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 144(8):541–553PubMedCrossRef
16.
Zurück zum Zitat Wampler NS, Saba L, Rahman SM, Dignan M, Voeks JH, Strzelczyk J (2006) Factors associated with adherence to recommendations for screening mammography among American Indian women in Colorado. Ethn Dis 16(4):808–814PubMed Wampler NS, Saba L, Rahman SM, Dignan M, Voeks JH, Strzelczyk J (2006) Factors associated with adherence to recommendations for screening mammography among American Indian women in Colorado. Ethn Dis 16(4):808–814PubMed
17.
Zurück zum Zitat Schumacher MC, Slattery ML, Lanier AP, Ma KN, Edwards S, Ferucci ED, Tom-Orme L (2008) Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control 19(7):725–737PubMedCrossRef Schumacher MC, Slattery ML, Lanier AP, Ma KN, Edwards S, Ferucci ED, Tom-Orme L (2008) Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control 19(7):725–737PubMedCrossRef
18.
Zurück zum Zitat Fan L, Mohile S, Zhang N, Fiscella K, Noyes K (2012) Self-reported cancer screening among elderly Medicare beneficiaries: a rural–urban comparison. J Rural Health 28(3):312–319PubMedCrossRef Fan L, Mohile S, Zhang N, Fiscella K, Noyes K (2012) Self-reported cancer screening among elderly Medicare beneficiaries: a rural–urban comparison. J Rural Health 28(3):312–319PubMedCrossRef
19.
Zurück zum Zitat Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, Wingo PA, Howe HL, Ries LA, Miller BA et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110(10):2119–2152PubMedCrossRef Espey DK, Wu XC, Swan J, Wiggins C, Jim MA, Ward E, Wingo PA, Howe HL, Ries LA, Miller BA et al (2007) Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives. Cancer 110(10):2119–2152PubMedCrossRef
21.
Zurück zum Zitat Watanabe-Galloway S, Flom N, Xu L, Duran T, Frerichs L, Kennedy F, Smith CB, Jaiyeola AO (2011) Cancer-related disparities and opportunities for intervention in Northern Plains American Indian communities. Public Health Rep 126(3):318–329PubMed Watanabe-Galloway S, Flom N, Xu L, Duran T, Frerichs L, Kennedy F, Smith CB, Jaiyeola AO (2011) Cancer-related disparities and opportunities for intervention in Northern Plains American Indian communities. Public Health Rep 126(3):318–329PubMed
23.
Zurück zum Zitat Rakowski W, Meissner H, Vernon SW, Breen N, Rimer B, Clark MA (2006) Correlates of repeat and recent mammography for women ages 45 to 75 in the 2002 to 2003 Health Information National Trends Survey (HINTS). Cancer Epidemiol Biomarkers Prev 15(11):2093–2101PubMedCrossRef Rakowski W, Meissner H, Vernon SW, Breen N, Rimer B, Clark MA (2006) Correlates of repeat and recent mammography for women ages 45 to 75 in the 2002 to 2003 Health Information National Trends Survey (HINTS). Cancer Epidemiol Biomarkers Prev 15(11):2093–2101PubMedCrossRef
24.
Zurück zum Zitat Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, Barlow WE, Geller BM, Kerlikowske K, Edwards BK et al (1997) Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 169(4):1001–1008PubMedCrossRef Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, Barlow WE, Geller BM, Kerlikowske K, Edwards BK et al (1997) Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 169(4):1001–1008PubMedCrossRef
25.
Zurück zum Zitat Cronin KA, Miglioretti DL, Krapcho M, Yu B, Geller BM, Carney PA, Onega T, Feuer EJ, Breen N, Ballard-Barbash R (2009) Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev 18(6):1699–1705PubMedCrossRef Cronin KA, Miglioretti DL, Krapcho M, Yu B, Geller BM, Carney PA, Onega T, Feuer EJ, Breen N, Ballard-Barbash R (2009) Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev 18(6):1699–1705PubMedCrossRef
26.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2010) Vital signs: breast cancer screening among women aged 50–74 years—United States, 2008. MMWR Morb Mortal Wkly Rep 59(26):813–816 Centers for Disease Control and Prevention (CDC) (2010) Vital signs: breast cancer screening among women aged 50–74 years—United States, 2008. MMWR Morb Mortal Wkly Rep 59(26):813–816
27.
Zurück zum Zitat Lanier AP, Kelly JJ, Holck P (1999) Pap prevalence and cervical cancer prevention among Alaska Native women. Health Care Women Int 20(5):471–486PubMedCrossRef Lanier AP, Kelly JJ, Holck P (1999) Pap prevalence and cervical cancer prevention among Alaska Native women. Health Care Women Int 20(5):471–486PubMedCrossRef
28.
Zurück zum Zitat Vyas A, Madhavan S, LeMasters T, Atkins E, Gainor S, Kennedy S, Kelly K, Vona-Davis L, Remick S (2012) Factors influencing adherence to mammography screening guidelines in Appalachian women participating in a mobile mammography program. J Community Health 37(3):632–646PubMedCrossRef Vyas A, Madhavan S, LeMasters T, Atkins E, Gainor S, Kennedy S, Kelly K, Vona-Davis L, Remick S (2012) Factors influencing adherence to mammography screening guidelines in Appalachian women participating in a mobile mammography program. J Community Health 37(3):632–646PubMedCrossRef
30.
Zurück zum Zitat Roubidoux MA (2012) Breast cancer and screening in American Indian and Alaska Native women. J Cancer Educ 27(Suppl 1):S66–S72PubMedCrossRef Roubidoux MA (2012) Breast cancer and screening in American Indian and Alaska Native women. J Cancer Educ 27(Suppl 1):S66–S72PubMedCrossRef
32.
Zurück zum Zitat Pandhi N, Guadagnolo BA, Kanekar S, Petereit DG, Smith MA (2010) Cancer screening in Native Americans from the Northern Plains. Am J Prev Med 38(4):389–395PubMedCrossRef Pandhi N, Guadagnolo BA, Kanekar S, Petereit DG, Smith MA (2010) Cancer screening in Native Americans from the Northern Plains. Am J Prev Med 38(4):389–395PubMedCrossRef
33.
Zurück zum Zitat Wampler NS, Ryschon T, Manson SM, Buchwald D (2006) Knowledge, attitudes, and beliefs regarding breast cancer among American Indian women from the Northern Plains. J Appl Gerontol 25(1 Suppl):44S–59SCrossRef Wampler NS, Ryschon T, Manson SM, Buchwald D (2006) Knowledge, attitudes, and beliefs regarding breast cancer among American Indian women from the Northern Plains. J Appl Gerontol 25(1 Suppl):44S–59SCrossRef
Metadaten
Titel
Adherence to screening mammography among American Indian women of the northern plains
verfasst von
Emily L. Roen
Marilyn A. Roubidoux
Annette I. Joe
Tina R. Russell
Amr S. Soliman
Publikationsdatum
01.06.2013
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2013
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2580-4

Weitere Artikel der Ausgabe 3/2013

Breast Cancer Research and Treatment 3/2013 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.